PRODUCTS / BROS
With unparalleled care and attention, we ensure the quality of our products at every step. Our products are manufactured in production facilities of our Company in new Kifissia, Attica.
products
active substance
primary use
CITROVENOT
F.C. TAB BT 10 x 750MG
Ciprofloxacin
Treatment of bacterial infections
KLARIBROS
F.C.TAB 500MG/TAB BT x 21
Clarithromycin
Treatment of bacterial infections
TIERLITE
CAPS 50MG/100 CAP BT x 7 - CAPS 50MG/CAP BT x 14
Fluconazole
Antifungal treatment
CEVINOLON
CREAM 5% ΤUΒ 10GR
Aciclovir
Treatment of infections caused by herpes simplex virus
products
active substance
primary use
SOTOMYCIN
SOL.EXT.US 1% FL X 60ML
Clindamycin Phospate
Treatment of acne
products
active substance
primary use
THEO-BROS
S.R.TAB 300MG/TAB BT X 30
Theophylline Anhydrous
Bronchial asthma, acute pulmonary edema, COPD and chronic bronchitis, when bronchospasm is reversible
products
active substance
primary use
REUMANISAL
CAPS 50MG/CAP BTx30
Diacerein
Treatment of symptoms in patients with οsteoarthritis of the hip or knee, with a delayed effect (Slow-acting drug)
products
active substance
primary use
ELKOTHERAN
E.C CAPS 28 χ 20MG
Omeprazole
Treatment of duodenal and gastric ulcers Treatment of symptomatic gastroesophageal reflux disease
products
active substance
primary use
SOTOVASTIN
F.C.TAB 30 x 40MG
Simvastatin
Treatment of hypercholesterolemia Prevention of cardiovascular events
DOSTUREL
TAB BT 20 x (50+25)MG
Captopril/Hydrochlorothiazide
Treatment of idiopathic hypertension
products
active substance
primary use
CHYMEXAN
300 MG BT x 20
Magnesium Oxide
Treatment of symptomatic hypomagnesemia
GNOSTORMON
CAPS 25.000IU/CAP BT x 4
Cholecalciferol (Vitamin D3)
Treatment of symptomatic vitamin D deficiency in adults
products
active substance
primary use
STEPHADILAT-S
CAPS BT 28 x 20MG
Fluoxetine Hydrochloride
Major depressive episodes Obsessive-compulsive disorder Bulimia nervosa
NEVRORESTOL
TAB. BT. 30 x 10MG
Buspirone Hydrochloride
Management of the symptoms of Generalised Anxiety Disorder
products
active substance
primary use
ZOCIVEN
F.C. TAB (50+850)MG/TAB - (50+1000)MG/TAB x 60 TABS
Vildagliptin/Metformin
Treatment of type 2 diabetes mellitus
products
active substance
primary use
BROSIRAL
INJ.SOL 15MG/1,5ML AMP BT x 5AMPS x1,5ML
Meloxicam
Short-term symptomatic treatment of acute exacerbations of rheumatoid arthritis and ankylosing spondylitis
EVINOPON
INJ.SOL 75MG/3ML AMP BT x 5AMP x 3ML
Diclofenac Sodium
Symptomatic treatment of chronic inflammatory arthropathies and degenerative arthritis.
products
active substance
primary use
PHACOCEF
PD.INJ.SOL BT x 1VIALx 1000MG + 1AMP x 10ML SOLV (IV)
Cefotaxime Sodium
Treatment of bacterial infections
FLEXELITE
INJ.SOL 500MG/2ML AMP BT x 1AMP x 2ML
Amicacin Sulfate
Treatment of bacterial infections
YOKEL
DR.PD.INJ 750MG/VIAL BTx1VIAL
Cefuroxime Sodium
Treatment of bacterial infections
IMICIL
PD.SOL.INF (500+500)MG/VIAL BTx 10 VIALS
Imipenem + Cilastatin
Treatment of bacterial infections
products
active substance
primary use
RESTFUL
INJ. SOL 100MG/2ML BT x 6AMPS x 2ML - BT x 30AMPS x 2ML
Sulpiride
Psychotic conditions, such as schizophrenia and organic psychosis
Caps & Powder for oral suspension in packs of 20 capsules and 200ml
ACTIVE SUBSTANCE
Erdosteine
INDICATIONS
For the liquefaction of mucus and mucopurulent secretions such as facilitating expectoration in exacerbations of chronic bronchitis and bronchiectasis
Pharmaceutical forms and composition of active ingredients
Capsules: Each capsule contains 300mg of Erdosteine
Powder for oral suspension: 5ml of suspension contains 175mg of Erdosteine
REFERENCE: Summary of Product Characteristics of THEOVIX
FLEVOSTOL (450+50) mg/tab, in packs of 30 film-coated tablets.
ACTIVE SUBSTANCE
Diosmin + Hesperidin
INDICATIONS
- Potentially acts as an adjunctive therapy in the treatment of complications of chronic venous insufficiency of the lower extremities.
- Symptomatic treatment of hemorrhoidal crisis
REFERENCE: Summary of Product Characteristics of FLEVOSTOL
REUMADOLOR
ACTIVE SUBSTANCE
Indomethacine 1% w/w
INDICATIONS
REUMADOLOR is indicated for local analgesia and anti-inflammatory action in the following cases when applied topically: - osteoarthritis - tendonitis - tenosynovitis - peritendonitis - epicondylitis - scapulohumeral periarthritis - post-traumatic edema and pain
REFERENCE: Summary of Product Characteristics of Reumadolor
EVINOPON cutaneous solution in 30ml and 60ml packaging & EVINOPON gel in packaging of 100g
ACTIVE SUBSTANCE
Cutaneous solution : 16mg/ml Diclofenac sodium
Gel : Diclofenac Diethylammonium 11,6mg
INDICATIONS
Cutaneous solution : It is indicated for the symptomatic relief of pain associated with osteoarthritis in superficial joints, including the knee. EVINOPON is applied locally to the joint.
Gel It is indicated for the symptomatic treatment of:
- Post-traumatic inflammation of tendons, ligaments, muscles and joints, due to e.g. sprains, dislocations, bruises
- Localized manifestations of pathological conditions of soft tissues
- Localized manifestations of degenerative arthropathies
REFERENCES: Summary of Product Characteristics of EVINOPON cutaneous solution and Summary of Product Characteristics of EVINOPON gel.
EBERSEPT shampoo 2% w/v in packaging of 120ml
ACTIVE SUBSTANCE
Each gram of shampoo contains 10mg or 20mg of ketoconazole.
INDICATIONS
EBERSEPT shampoo 2% is indicated for the treatment and prevention of severe dandruff of the scalp (dandruff).
REFERENCE: Summary of Product Characteristics of Product EBERSEPT
PHACOVIT oral solution of L- Carnitine in packaging of 10 vials of 10ml
ACTIVE SUBSTANCE
Each 10ml vial of oral solution contains 1 g of L-Carnitine.
INDICATIONS
PHACOVIT is indicated for the primary and secondary deficiency of L-carnitine
REFERENCE: Summary of Product Characteristics of PHACOVIT
PRODUCT PRODUCTION & STORAGE
Bros production department consists of experienced and highly trained staff and is equipped with state-of-the-art machinery, which together with purity raw materials, guarantees the production of high quality products. Bros has a 2,000 m² production facility in Attica, certified with GMP. It has the capacity to produce multiple pharmaceutical forms, such as tablets, capsules, injectable liquids, dry injectables, suspensions, semisolids, etc. In addition, the Bros production facility offers a range of pharmaceutical products, including 6 OTC (over the counter) medications.
The Bros factory produces most of Vocate products. Vocate acquired Bros in 2018.
Bros production facility.
In May 2018, Vocate acquired its own production facility by purchasing the Pharmaceutical industry BrosBros has a 2,000 m² production facility in Attica, certified with GMP. It has the capacity to produce multiple pharmaceutical forms, such as tablets, capsules, injectable liquids, dry injectables, suspensions, semisolids, etc. In addition, the Bros production facility offers a range of pharmaceutical products, including 6 OTC (over-the-counter) medications.
See more on the Vocate website
CONTACT US
English 
Greek